Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients

American Journal of Transplantation

Volumn 9, Issue 12, 2009, Pages 2845-2850

  Wang, T F ^a   Wang, T ^a   Altman, R ^a   Eshaghian, P ^a   Lynch, J P ^a   Ross, D J ^a   Belperio, J A ^a   Weigt, S S ^a   Gregson, A ^a   Kubak, B ^a   Saggar, R ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

Drug reactions; Drug toxicity; Lung transplantation; Voriconazole

Indexed keywords

ALKALINE PHOSPHATASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINIC ACID; PRAVASTATIN; PREDNISONE; RADIOISOTOPE; TACROLIMUS; VORICONAZOLE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; BONE PAIN; BONE SCINTISCANNING; BRONCHIECTASIS; BRONCHOSCOPY; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG WITHDRAWAL; DYSESTHESIA; FEMALE; HUMAN; HYPERTROPHIC OSTEOARTHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LONG TERM CARE; LUNG; LUNG ASPERGILLOSIS; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MUSCULOSKELETAL PAIN; MYALGIA; PERIOSTITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RADIODIAGNOSIS; SARCOIDOSIS; SERUM CHARACTERISTICS;

ADULT; AGED; ALKALINE PHOSPHATASE; ANTIFUNGAL AGENTS; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PERIOSTITIS; PULMONARY ASPERGILLOSIS; PYRIMIDINES; TRIAZOLES;

EID: 72449144605     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02837.x     Document Type: Article

References (17)

1. Singh N, Husain S. Aspergillus infections after lung transplantation: Clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003 22 : 258 266.
2. Cahill BC, Hibbs JR, Savik K et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997 112 : 1160 1164.
3. Mehrad B, Paciocco G, Martinez FJ, Ojo TC, Iannettoni MD, Lynch JP 3rd. Spectrum of Aspergillus infection in lung transplant recipients: Case series and review of the literature. Chest 2001 119 : 169 175.
4. Martinez-Lavin M, Matucci-Cerinic M, Jajic I, Pineda C. Hypertrophic osteoarthropathy: Consensus on its definition, classification, assessment and diagnostic criteria. J Rheumatol 1993 20 : 1386 1387.
5. Boussaud V, Daudet N, Billaud EM et al. Neuromuscular painful disorders: A rare side effect of voriconazole in lung transplant patients under tacrolimus. J Heart Lung Transplant 2008 27 : 229 232.
6. Aksoy F, Akdogan E, Aydin K et al. Voriconazole-induced neuropathy. Chemotherapy 2008 54 : 224 227.
7. Voriconazole [Package Insert]. New York, USA : Pfizer Inc. 2008.
8. Yao Q, Altman RD, Brahn E. Periostitis and hypertrophic pulmonary osteoarthropathy: Report of 2 Cases and Review of the Literature. Semin Arthritis Rheum 2008 38 : 458 466.
9. Uppal S, Diggle CP, Carr IM et al. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 2008 40 : 789 793.
10. Altman RD. Hypertrophic osteoarthropathy. 14th ed. Philadelphia, PA : Lippincott Williams & Wilkins, 2001.
11. Altman RD. Hypertrophic osteoarthropathy. 6th ed. Philadelphia, PA : WB Saunders, 2001.
12. Silveri F, De Angelis R, Argentati F, Brecciaroli D, Muti S, Cervini C. Hypertrophic osteoarthropathy: Endothelium and platelet function. Clin Rheumatol 1996 15 : 435 439.
13. Silveira LH, Martinez-Lavin M, Pineda C, Fonseca MC, Navarro C, Nava A. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000 18 : 57 62.
14. Ringel RE, Brenner JI, Haney PJ, Burns JE, Moulton AL, Berman MA. Prostaglandin-induced periostitis: A complication of long-term PGE1 infusion in an infant with congenital heart disease. Radiology 1982 142 : 657 658.
15. Ueda K, Saito A, Nakano H et al. Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. J Pediatr 1980 97 : 834 836.
16. Weigt SS, Elashoff RM, Huang C et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant 2009 9 : 1903 1911.
17. Fungal infections. Am J Transplant 2004 4 (Suppl 10 110 134.